Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3345313rdf:typepubmed:Citationlld:pubmed
pubmed-article:3345313lifeskim:mentionsumls-concept:C0003392lld:lifeskim
pubmed-article:3345313lifeskim:mentionsumls-concept:C0007125lld:lifeskim
pubmed-article:3345313lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:3345313lifeskim:mentionsumls-concept:C0431085lld:lifeskim
pubmed-article:3345313lifeskim:mentionsumls-concept:C0014994lld:lifeskim
pubmed-article:3345313lifeskim:mentionsumls-concept:C0017950lld:lifeskim
pubmed-article:3345313lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:3345313pubmed:issue1lld:pubmed
pubmed-article:3345313pubmed:dateCreated1988-4-11lld:pubmed
pubmed-article:3345313pubmed:abstractTextEhrlich ascites tumor cells were incubated in vitro with rac-1-O-[1'-14C]octadecyl-2-O-methylglycero-3-beta-D-glucopyranosi de for 24 h. The potentially antineoplastic ether glycolipid was rapidly metabolized by the cells to radioactive 1-O-octadecyl-2-O-methylglycerol (70 pmol/10(6) cells per h) and further acylated to 1-O-octadecyl-2-O-methyl-3-acylglycerols. Incubation of Ehrlich ascites cells with synthetic rac-1-O-[1'-14C]octadecyl-2-O-methyl-3-palmitoylglycerol showed that this metabolite is reconverted by deacylation to 14C-labeled 1-O-octadecyl-2-O-methylglycerol. The latter compound or a metabolite derived therefrom may be the 'toxic principle' of both the ether glyceroglycolipids and ether glycerophospholipids having a 1-O-alkyl-2-O-methylglyceryl moiety, as suggested by Unger et al. (J. Natl. Cancer Inst. 78 (1987) 219-222).lld:pubmed
pubmed-article:3345313pubmed:languageenglld:pubmed
pubmed-article:3345313pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3345313pubmed:citationSubsetIMlld:pubmed
pubmed-article:3345313pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3345313pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3345313pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3345313pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3345313pubmed:statusMEDLINElld:pubmed
pubmed-article:3345313pubmed:monthMarlld:pubmed
pubmed-article:3345313pubmed:issn0006-3002lld:pubmed
pubmed-article:3345313pubmed:authorpubmed-author:WeberNNlld:pubmed
pubmed-article:3345313pubmed:authorpubmed-author:BenningHHlld:pubmed
pubmed-article:3345313pubmed:issnTypePrintlld:pubmed
pubmed-article:3345313pubmed:day4lld:pubmed
pubmed-article:3345313pubmed:volume959lld:pubmed
pubmed-article:3345313pubmed:ownerNLMlld:pubmed
pubmed-article:3345313pubmed:authorsCompleteYlld:pubmed
pubmed-article:3345313pubmed:pagination91-4lld:pubmed
pubmed-article:3345313pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3345313pubmed:meshHeadingpubmed-meshheading:3345313-...lld:pubmed
pubmed-article:3345313pubmed:meshHeadingpubmed-meshheading:3345313-...lld:pubmed
pubmed-article:3345313pubmed:meshHeadingpubmed-meshheading:3345313-...lld:pubmed
pubmed-article:3345313pubmed:meshHeadingpubmed-meshheading:3345313-...lld:pubmed
pubmed-article:3345313pubmed:meshHeadingpubmed-meshheading:3345313-...lld:pubmed
pubmed-article:3345313pubmed:meshHeadingpubmed-meshheading:3345313-...lld:pubmed
pubmed-article:3345313pubmed:meshHeadingpubmed-meshheading:3345313-...lld:pubmed
pubmed-article:3345313pubmed:meshHeadingpubmed-meshheading:3345313-...lld:pubmed
pubmed-article:3345313pubmed:year1988lld:pubmed
pubmed-article:3345313pubmed:articleTitleMetabolism of ether glycolipids with potentially antineoplastic activity by Ehrlich ascites tumor cells.lld:pubmed
pubmed-article:3345313pubmed:affiliationBundesanstalt für Fettforschung, Institut für Biochemie und Technologie, H.P. Kaufmann-Institut, Münster, F.R.G.lld:pubmed
pubmed-article:3345313pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3345313pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3345313lld:pubmed